Iovance Biotherapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC IOVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,753,343

Value ($000)

7,517

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,517	0.0%	2,753,343	12/31/2025
2025 Q3	11/10/2025	5,435	0.0%	2,504,542	9/30/2025
2025 Q2	8/12/2025	3,296	0.0%	1,916,486	6/30/2025
2025 Q1	9/15/2025	6,153	0.0%	1,847,741	3/31/2025
2024 Q4	2/6/2025	14,721	0.0%	1,989,340	12/31/2024
2024 Q3	11/12/2024	17,964	0.0%	1,913,144	9/30/2024
2024 Q2	8/12/2024	15,919	0.0%	1,984,945	6/30/2024
2024 Q1	5/9/2024	28,352	0.0%	1,913,100	3/31/2024
2023 Q4	2/6/2024	14,203	0.0%	1,747,023	12/31/2023
2023 Q3	11/8/2023	7,701	0.0%	1,692,533	9/30/2023
2023 Q2	8/10/2023	10,498	0.0%	1,491,222	6/30/2023
2023 Q1	5/12/2023	6,451	0.0%	1,055,852	3/31/2023
2022 Q4	2/13/2023	6,740	0.0%	1,054,844	12/31/2022
2022 Q3	11/14/2022	9,844	0.0%	1,027,460	9/30/2022
2022 Q2	8/15/2022	11,046	0.0%	1,000,472	6/30/2022
2022 Q1	5/13/2022	11,780	0.0%	707,496	3/31/2022
2021 Q4	2/11/2022	13,086	0.0%	685,459	12/31/2021
2021 Q3	11/16/2021	16,421	0.0%	665,896	9/30/2021
2021 Q2	8/16/2021	19,656	0.0%	755,416	6/30/2021
2021 Q1	5/17/2021	22,437	0.0%	708,658	3/31/2021
2020 Q4	2/16/2021	30,126	0.0%	649,257	12/31/2020
2020 Q3	11/13/2020	21,032	0.0%	638,870	9/30/2020
2020 Q2	8/20/2020	17,170	0.0%	625,487	6/30/2020
2020 Q1	5/15/2020	22,222	0.0%	742,310	3/31/2020
2019 Q4	2/7/2020	20,193	0.0%	729,497	12/31/2019